← Back
Data updated: Mar 10, 2026
WILSHIRE PHARMS INC
ImmunologyRespiratoryGastroenterology
WILSHIRE PHARMS INC is a generic drug manufacturer focused on Immunology, Respiratory, Gastroenterology. Key products include DEXMEDETOMIDINE HYDROCHLORIDE.
2015
Since
11
Drugs
-
Trials
74
Approved (2yr)
Key Drugs
Recent Activity
DEXMEDETOMIDINE HYDROCHLORIDE 2026-02-17
Labeling
METHYLPREDNISOLONE ACETATE 2026-01-26
METHYLPREDNISOLONE ACETATE 2026-01-20
Labeling
METHYLPREDNISOLONE ACETATE 2026-01-20
Labeling
TESTOSTERONE CYPIONATE 2025-07-21
Labeling
TESTOSTERONE CYPIONATE 2025-07-21
Labeling
TESTOSTERONE CYPIONATE 2025-07-14
Labeling
TESTOSTERONE CYPIONATE 2025-07-11
Labeling
TESTOSTERONE CYPIONATE 2025-07-11
Labeling
TESTOSTERONE CYPIONATE 2025-07-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 32%
0 drugs Phase 3: 7
Respiratory 22%
3 drugs Phase 1: 1
Gastroenterology 18%
0 drugs Phase 3: 4
Metabolic 14%
0 drugs Phase 3: 2 Phase 1: 4
Infectious Disease 14%
0 drugs Phase 3: 3
Pipeline Strength Pro
Loading...
Competitors Pro
Sanofi big-pharma
Metabolic, Infectious Disease, Immunology, Respiratory
Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Merck big-pharma
Infectious Disease, Immunology, Metabolic
PHARMACIA AND UPJOHN big-pharma
Infectious Disease, Respiratory, Immunology, Metabolic
Gilead Sciences biotech
Infectious Disease, Immunology, Gastroenterology, Respiratory
Active (9)
Discontinued (2)
Company Info
- First Approval
- 2015-12-17
- Latest
- 2025-07-11
- Applications
- 12